Healthcare Triangle
HCTI
3 hedge funds and large institutions have $51.6K invested in Healthcare Triangle in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
40% less funds holding
Funds holding: 5 → 3 (-2)
40% less capital invested
Capital invested by funds: $86.5K → $51.6K (-$34.9K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.6K |
| 2 |
Morgan Stanley
New York
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$58K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$12.6K |
| 3 |
Two Sigma Investments
New York
|
-$11.7K |
HCTI Hedge Fund Activity: Q4 2024 in Review
3 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Healthcare Triangle (HCTI) for Q4 2024, worth a combined $51.6K — down 40% from $86.5K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of HCTI and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Geode Capital Management, adding an estimated $12.6K. The largest seller was UBS Group, exiting entirely with an estimated $58K sold.
- 3 institutional investors held Healthcare Triangle (HCTI) as of Q4 2024, down from 5 in Q3 2024.
- Funds reported $51.6K of Healthcare Triangle stock for Q4 2024, down 40% quarter-over-quarter.
- 1 fund opened new Healthcare Triangle positions in Q4 2024 and 3 closed out, a net change of -2 holders.
- The largest Healthcare Triangle buyer in Q4 2024 was Geode Capital Management, an estimated $12.6K added.
- The largest Healthcare Triangle seller in Q4 2024 was UBS Group, an estimated $58K sold.
Based on aggregated 13F filings for Q4 2024.